• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Resistance among important pathogens and the antimicrobial activity of parenteral fluoroquinolones at 43 US medical centres.

作者信息

Jones R N, Kehrberg E N, Erwin M E

机构信息

Department of Pathology, University of Iowa College of Medicine, Iowa City, USA.

出版信息

Drugs. 1995;49 Suppl 2:179-81. doi: 10.2165/00003495-199500492-00033.

DOI:10.2165/00003495-199500492-00033
PMID:8549295
Abstract
摘要

相似文献

1
Resistance among important pathogens and the antimicrobial activity of parenteral fluoroquinolones at 43 US medical centres.美国43家医疗中心重要病原体的耐药性及胃肠外氟喹诺酮类药物的抗菌活性
Drugs. 1995;49 Suppl 2:179-81. doi: 10.2165/00003495-199500492-00033.
2
Fluoroquinolone resistance: mechanisms and epidemiology.氟喹诺酮耐药性：机制与流行病学
J Med Microbiol. 1997 Jun;46(6):457-61.
3
Emergence of resistance to fluoroquinolones among bacteria causing infections in food animals in Denmark.
Vet Rec. 2000 Jan 15;146(3):76-8. doi: 10.1136/vr.146.3.76.
4
In vitro antimicrobial activity of CP-99,219, a new 7-azabicyclonaphthyridone.
Drugs. 1995;49 Suppl 2:205-7. doi: 10.2165/00003495-199500492-00043.
5
Epidemiology of quinolone resistance: Europe and North and South America.喹诺酮耐药性的流行病学：欧洲及南北美洲
Drugs. 1995;49 Suppl 2:36-42. doi: 10.2165/00003495-199500492-00007.
6
In-vitro activity of E-4695, a new fluoronaphthyridine antimicrobial agent.新型氟萘啶抗菌剂E-4695的体外活性
J Antimicrob Chemother. 1994 May;33(5):1017-23. doi: 10.1093/jac/33.5.1017.
7
[Tosufloxacin tosilate].[妥舒沙星甲苯磺酸盐]
Jpn J Antibiot. 1990 Apr;43(4):583-602.
8
Changes in susceptibility to ciprofloxacin in a community in northern Israel.
Drugs. 1995;49 Suppl 2:173-4. doi: 10.2165/00003495-199500492-00030.
9
Susceptibility of recent clinical isolates to temafloxacin (A-63004) and other antimicrobial agents.近期临床分离株对替马沙星（A-63004）及其他抗菌药物的敏感性。
Drugs Exp Clin Res. 1992;18(8):311-7.
10
In vitro and in vivo antibacterial activities of CFC-222, a novel broad spectrum fluoroquinolone.
Drugs. 1995;49 Suppl 2:240-2. doi: 10.2165/00003495-199500492-00055.

引用本文的文献

1
Quinolones: which generation for which microbe?喹诺酮类药物：针对哪种微生物该用哪一代？
West J Med. 1999 Jun;170(6):359-61.
2
In vitro activity of fleroxacin against multiresistant gram-negative bacilli isolated from patients with nosocomial infections.氟罗沙星对从医院感染患者中分离出的多重耐药革兰氏阴性杆菌的体外活性。
Intensive Care Med. 1998 Aug;24(8):839-44. doi: 10.1007/s001340050675.

本文引用的文献

1
The North American component (the United States and Canada) of an International Comparative MIC trial monitoring ofloxacin resistance.一项国际比较性最低抑菌浓度（MIC）试验中对氧氟沙星耐药性监测的北美部分（美国和加拿大）。
Diagn Microbiol Infect Dis. 1993 Aug-Sep;17(2):157-61. doi: 10.1016/0732-8893(93)90027-5.
2
Inactivation of antibiotics and the dissemination of resistance genes.抗生素的失活与耐药基因的传播。
Science. 1994 Apr 15;264(5157):375-82. doi: 10.1126/science.8153624.
3
Multiple-antibiotic-resistant pathogenic bacteria. A report on the Rockefeller University Workshop.
多重耐药病原菌。洛克菲勒大学研讨会报告。
N Engl J Med. 1994 Apr 28;330(17):1247-51. doi: 10.1056/NEJM199404283301725.
4
North American (United States and Canada) comparative susceptibility of two fluoroquinolones: ofloxacin and ciprofloxacin. A 53-medical-center sample of spectra of activity. North American Ofloxacin Study Group.北美（美国和加拿大）两种氟喹诺酮类药物（氧氟沙星和环丙沙星）的敏感性比较。53个医学中心的活性谱样本。北美氧氟沙星研究组。
Diagn Microbiol Infect Dis. 1994 Jan;18(1):49-56. doi: 10.1016/0732-8893(94)90133-3.
5
Ofloxacin, a new broad-spectrum fluoroquinolone. Results from a Multicenter, National Comparative Activity Surveillance Study. The Ofloxacin Surveillance Group.
Diagn Microbiol Infect Dis. 1992 Jul;15(5):425-34. doi: 10.1016/0732-8893(92)90084-7.